Search results

Technologies 1

• Implantable Cancer Vaccine
  The Wyss Institute’s implantable, biodegradable cancer vaccine leverages immunotherapeutic methods and could one day help overcome melanoma, other cancers, infectious diseases, auto-immune diseases, as well as vaccinate against specific peptides, proteins, or antigens. The implant is a biodegradable polymer scaffold containing growth factors and components of each patient’s tumors. The technology was initially designed to...

News 8

View all

• Research Spotlights
  
  i3 Center: Biomaterials to Create T Cell Immunity
  July 1, 2020
• Awards
  
  Harvard’s Wyss Institute announces cross-institutional “Immuno-engineering to Improve Immunotherapy (i3)” Center to advance cancer therapy
  March 6, 2020
• Press Release
  
  A solid vaccine for liquid tumors
  January 14, 2020